Impact of Renin-Angiotensin System Inhibition on Microalbuminuria in Type 2 Diabetes: A Post Hoc Analysis of the Shiga Microalbuminuria Reduction Trial (SMART)-Reference-Cited by-同舟云学术

Impact of Renin-Angiotensin System Inhibition on Microalbuminuria in Type 2 Diabetes: A Post Hoc Analysis of the Shiga Microalbuminuria Reduction Trial (SMART)

Published:2008 Issue:6 Volume:31 Page:1171-1176
ISSN:0916-9636
Container-title:Hypertension Research
language:en
Short-container-title:Hypertens Res

Author:

The Shiga Microalbuminuria Reductio

Publisher

Japanese Society of Hypertension

Subject

Cardiology and Cardiovascular Medicine,Physiology,Internal Medicine

Reference24 articles.

1. 1. Parving HH, Lehnert H, Brochner-Mortensen J, Gomis R, Andersen S, Arner P, Irbesartan in Patients with Type 2 Diabetes and Microalbuminuria Study Group: The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N Engl J Med 2001; 345: 870-878.

2. 2. Brenner BM, Cooper ME, de Zeeuw D, et al: Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 2001; 345: 861-869.

3. Microalbuminuria Reduction With Valsartan in Patients With Type 2 Diabetes Mellitus

4. 4. Jafar TH, Stark PC, Schmid CH, et al: Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis. Ann Intern Med 2003; 139: 244-253.

5. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood PressureThe JNC 7 Report

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Doping Doctors: The Influence of the Marketing Departments of Pharmaceutical Companies on Physician and Researcher Behavior in Japan;Accountability in Research;2016-02

2. Efficacy and safety of valsartan in reducing blood pressure and albuminuria in Chinese patients with essential hypertension: a multicenter prospective open-label observational study;Current Medical Research and Opinion;2012-10-01

3. Switching to an L/N-Type Calcium Channel Blocker Shows Renoprotective Effects in Patients with Chronic Kidney Disease: The Kyoto Cilnidipine Study;Journal of International Medical Research;2012-08

4. Modulation of renal superoxide dismutase by telmisartan therapy in C57BL/6-Ins2Akita diabetic mice;Hypertension Research;2011-11-10

5. Effects of valsartan and amlodipine on home blood pressure and cardiovascular events in Japanese hypertensive patients: a subanalysis of the VART;Journal of Human Hypertension;2011-10-13